Plasma Levels of Fetuin B and Fibrinogen in Chronic Obstructive Pulmonary Disease: A Preliminary Cross-sectional Study

Introduction: Recent exploratory proteomics study reported increased blood levels of Fetuin B (FETUB) in Chronic Obstructive Pulmonary Disease (COPD). Growing body of evidence demonstrates fibrinogen not only as acute phase reactant but also possesses features advocating as biomarker of COPD....

Full description

Bibliographic Details
Main Authors: CV Shri Swathini, MVP Chowdary
Format: Article
Language:English
Published: JCDR Research and Publications Private Limited 2021-09-01
Series:Journal of Clinical and Diagnostic Research
Subjects:
Online Access:https://www.jcdr.net/articles/PDF/15377/49391_CE[Ra1]_F[SK]_PF1(MG_SHU)_PFA_PB(MG_KM)_PN(KM).pdf
_version_ 1830083428078321664
author CV Shri Swathini
MVP Chowdary
author_facet CV Shri Swathini
MVP Chowdary
author_sort CV Shri Swathini
collection DOAJ
description Introduction: Recent exploratory proteomics study reported increased blood levels of Fetuin B (FETUB) in Chronic Obstructive Pulmonary Disease (COPD). Growing body of evidence demonstrates fibrinogen not only as acute phase reactant but also possesses features advocating as biomarker of COPD. Aim: To determine the blood levels of FETUB and fibrinogen independently as well as in combination COPD and among severity of COPD. Materials and Methods: A single-centred cross-sectional study of eight months duration was conducted during May to December 2017. A total of 76 blood samples (38 COPD patients and 38 controls) were recruited. Based on distribution, parametric and non parametric statistical tools were used. Analysis of co-variance and multiple multivariate linear regression models were utilised to assess the influence of clinical data on FETUB. Steel-Dwass-CritchlowFligner method was employed for multiple pairwise comparisons. Receiver Operating Characteristic (ROC) curve were generated to compute cut-off of FETUB, fibrinogen and their combination. Results: The median age of subjects were 57 years with an IQR of 50-66 years for controls whereas 58 years (IQR 50-65 years) for COPD subjects. In comparison to controls, a significant increase in blood levels of both FETUB and fibrinogen in COPD and Global Initiative for Chronic Obstructive Lung Disease (GOLD) stages of COPD was prominent. Among COPD grades, differences of FETUB levels were significant in GOLD I vs II and GOLD IV vs I, II and III whereas fibrinogen levels in GOLD III from GOLD IV. FETUB showed independent correlation with Forced Expiratory Volume (FEV) 1% pred and severity of COPD. A moderate improvement in combined (FETUB+fibrinogen) analysis of control vs COPD was noticed. Conclusion: The present study demonstrates significant increase in blood levels of FETUB in COPD and among the severity of COPD in comparison to fibrinogen. Hence, FETUB can be a more promising probable inflammatory biomarker in COPD.
first_indexed 2024-12-14T16:21:29Z
format Article
id doaj.art-d6be8d5f8b1d45da8897b80f0e0f5e6f
institution Directory Open Access Journal
issn 2249-782X
0973-709X
language English
last_indexed 2024-12-14T16:21:29Z
publishDate 2021-09-01
publisher JCDR Research and Publications Private Limited
record_format Article
series Journal of Clinical and Diagnostic Research
spelling doaj.art-d6be8d5f8b1d45da8897b80f0e0f5e6f2022-12-21T22:54:47ZengJCDR Research and Publications Private LimitedJournal of Clinical and Diagnostic Research2249-782X0973-709X2021-09-01159BC08BC1310.7860/JCDR/2021/49391.15377Plasma Levels of Fetuin B and Fibrinogen in Chronic Obstructive Pulmonary Disease: A Preliminary Cross-sectional StudyCV Shri Swathini0MVP Chowdary1Residential Intern, Department of Biochemistry, Karpagam Faculty of Medical Sciences and Research, Coimbatore, Tamil Nadu, IndiaAssociate Professor, Department of Biochemistry, KMCH Institute of Health Sciences and Research, Coimbatore, Tamil Nadu, India.Introduction: Recent exploratory proteomics study reported increased blood levels of Fetuin B (FETUB) in Chronic Obstructive Pulmonary Disease (COPD). Growing body of evidence demonstrates fibrinogen not only as acute phase reactant but also possesses features advocating as biomarker of COPD. Aim: To determine the blood levels of FETUB and fibrinogen independently as well as in combination COPD and among severity of COPD. Materials and Methods: A single-centred cross-sectional study of eight months duration was conducted during May to December 2017. A total of 76 blood samples (38 COPD patients and 38 controls) were recruited. Based on distribution, parametric and non parametric statistical tools were used. Analysis of co-variance and multiple multivariate linear regression models were utilised to assess the influence of clinical data on FETUB. Steel-Dwass-CritchlowFligner method was employed for multiple pairwise comparisons. Receiver Operating Characteristic (ROC) curve were generated to compute cut-off of FETUB, fibrinogen and their combination. Results: The median age of subjects were 57 years with an IQR of 50-66 years for controls whereas 58 years (IQR 50-65 years) for COPD subjects. In comparison to controls, a significant increase in blood levels of both FETUB and fibrinogen in COPD and Global Initiative for Chronic Obstructive Lung Disease (GOLD) stages of COPD was prominent. Among COPD grades, differences of FETUB levels were significant in GOLD I vs II and GOLD IV vs I, II and III whereas fibrinogen levels in GOLD III from GOLD IV. FETUB showed independent correlation with Forced Expiratory Volume (FEV) 1% pred and severity of COPD. A moderate improvement in combined (FETUB+fibrinogen) analysis of control vs COPD was noticed. Conclusion: The present study demonstrates significant increase in blood levels of FETUB in COPD and among the severity of COPD in comparison to fibrinogen. Hence, FETUB can be a more promising probable inflammatory biomarker in COPD.https://www.jcdr.net/articles/PDF/15377/49391_CE[Ra1]_F[SK]_PF1(MG_SHU)_PFA_PB(MG_KM)_PN(KM).pdfforced expiratory volumeglobal initiative for chronic obstructive lung diseasesmoking and biomass exposure
spellingShingle CV Shri Swathini
MVP Chowdary
Plasma Levels of Fetuin B and Fibrinogen in Chronic Obstructive Pulmonary Disease: A Preliminary Cross-sectional Study
Journal of Clinical and Diagnostic Research
forced expiratory volume
global initiative for chronic obstructive lung disease
smoking and biomass exposure
title Plasma Levels of Fetuin B and Fibrinogen in Chronic Obstructive Pulmonary Disease: A Preliminary Cross-sectional Study
title_full Plasma Levels of Fetuin B and Fibrinogen in Chronic Obstructive Pulmonary Disease: A Preliminary Cross-sectional Study
title_fullStr Plasma Levels of Fetuin B and Fibrinogen in Chronic Obstructive Pulmonary Disease: A Preliminary Cross-sectional Study
title_full_unstemmed Plasma Levels of Fetuin B and Fibrinogen in Chronic Obstructive Pulmonary Disease: A Preliminary Cross-sectional Study
title_short Plasma Levels of Fetuin B and Fibrinogen in Chronic Obstructive Pulmonary Disease: A Preliminary Cross-sectional Study
title_sort plasma levels of fetuin b and fibrinogen in chronic obstructive pulmonary disease a preliminary cross sectional study
topic forced expiratory volume
global initiative for chronic obstructive lung disease
smoking and biomass exposure
url https://www.jcdr.net/articles/PDF/15377/49391_CE[Ra1]_F[SK]_PF1(MG_SHU)_PFA_PB(MG_KM)_PN(KM).pdf
work_keys_str_mv AT cvshriswathini plasmalevelsoffetuinbandfibrinogeninchronicobstructivepulmonarydiseaseapreliminarycrosssectionalstudy
AT mvpchowdary plasmalevelsoffetuinbandfibrinogeninchronicobstructivepulmonarydiseaseapreliminarycrosssectionalstudy